BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25783529)

  • 1. Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients.
    Su J; Guo B; Zhang T; Wang K; Li X; Liang G
    Tumour Biol; 2015 Aug; 36(8):6333-9. PubMed ID: 25783529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of microRNA-10b upregulation and poor prognosis in human gliomas.
    Ji Y; Wei Y; Wang J; Gong K; Zhang Y; Zuo H
    Tumour Biol; 2015 Aug; 36(8):6249-54. PubMed ID: 25773393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stanniocalcin 1 is a prognostic biomarker in glioma.
    Luo W; Chen D; Wang H; Hu J
    Oncol Lett; 2020 Sep; 20(3):2248-2256. PubMed ID: 32782542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of microRNA-107 predicts poorer prognosis in glioma.
    Ji Y; Wei Y; Wang J; Ao Q; Gong K; Zuo H
    Tumour Biol; 2015 Jun; 36(6):4461-6. PubMed ID: 25596705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
    Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
    J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma.
    Sibin MK; Bhat DI; Narasingarao KV; Lavanya Ch; Chetan GK
    Tumour Biol; 2015 Sep; 36(10):7607-14. PubMed ID: 25921285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
    Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.
    Sun G; Yan S; Shi L; Wan Z; Jiang N; Li M; Guo J
    Cancer Biother Radiopharm; 2015 May; 30(4):169-73. PubMed ID: 25811315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 expression as a marker for predicting clinical outcome in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    J Biomed Biotechnol; 2012; 2012():517172. PubMed ID: 22500096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.
    Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z
    Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients.
    Zheng J; Dong W; Zhang J; Li G; Gong H
    Acta Biochim Biophys Sin (Shanghai); 2016 Apr; 48(4):318-25. PubMed ID: 26936129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
    He S; Deng J; Li G; Wang B; Cao Y; Tu Y
    Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.